Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Mama Bear who wrote (2039)	1/24/1998 11:34:00 PM
From: Dauntless	Read Replies (5) \| Respond to of 7041

To Zonagen LONGS - (not you Barb) In the next day or two I will providing information on the 1975 phentolamine study on which Asensio based his attack on Vasomax. I have that study as well as a FOLLOW-UP study, done by the same group at Ciba-Geigy in 1981 - which tells a significantly different story. Shortly after that (probably monday) I will have in my possession a copy of the lawsuit filed against Zonagen by their ex-director of immunology which was the basis of another attack by Asensio on Zonagen. I am anxious to learn & share with the longs on this thread the real charges filed by this ex employee. I've had a hard time understanding just why he would file a suit charging Zonagen with filing a "fraudulent patent application". I suspect this was mis-reported "just a bit". I have been lurking & reading all the wonderful (and original) posts from the shorts - I really didn't have to because they haven't changed since they first appeared. Anyway, I will post documented information, maybe a couple of times. The upcoming milestones that Zonagen will be anouncing will finally end all this BS & the vultures can go off looking for their next carcass. God, what a mind-set it must take to act as they do.